BioSpace News Archive

Drug pricing

TrumpRx Delayed Amid Potential Anti-Kickback Concerns

In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.

January 30, 2026
·
2 min read
·
Tristan Manalac
Deals

Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M

Moderna will continue to lead clinical development and manufacturing of the asset, while Recordati will handle commercialization of mRNA-3927, which is under development for the rare metabolic disorder propionic acidemia.

January 30, 2026
·
1 min read
·
Annalee Armstrong
Cancer

FDA’s Multiple Myeloma Guidance Highlights Decade of Success

New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments.

January 30, 2026
·
4 min read
·
Dan Samorodnitsky
Rare diseases

Despite Wide Support for Rare Disease, Voucher Program Caught Up in Senate’s ICE Fight

The Senate failed to pass a massive spending bill on Thursday—which includes the rare pediatric PRV program but also funding for the Immigration and Customs Enforcement’s large-scale crackdown in Minnesota and other states.

January 30, 2026
·
3 min read
·
Annalee Armstrong